Urgent.News

What's breaking now, across thousands of outlets.

Culture

Kane says Champions League glory would mean more than Ballon d’Or

MADRID, Nov 3 — Ballon d’Or winner Harry Kane said Monday he would trade that accolade for the Champions Lea...

Kane says Champions League glory would mean more than Ballon d’Or

Harry Kane, the 33-year-old striker, expressed on Monday that he would choose the Champions League trophy over the Ballon d’Or if he had to pick between the two accolades. The England international recently won the Ballon d’Or, surpassing stars like Kylian Mbappe and Lamine Yamal. However, Kane emphasized that team trophies are the reason he plays the game, with the team aspect of their sport being of utmost importance.

Speaking at a press conference in Madrid, Kane stated that the reason he plays football is to enjoy success with his teammates and to lift the Champions League with Bayern Munich. He added that while the Ballon d’Or was one of the best feelings he's had in his life and career, the opportunity to experience the emotion with his team-mates in big finals would be an incredible feeling.

Atletico coach Diego Simeone praised Kane as an "incredible player" and "very good for football." Kane thanked Simeone, who is one of the best coaches of this era, for his praise. The match against Atletico Munich takes place on Tuesday.

Written by urgent.news from Malay Mail's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at malaymail.com →

More in Culture

Dame Sarr scores 16 as No. 2 Duke beats Army 84-50 in opener

(AP) — Dame Sarr scored 16 points and freshman Joaquim Boumtje Boumtje had 15 points in his collegiate debut as No. 2 Duke had big scoring runs to begin each half in an 84-50 season-opening win over…

  • Dame Sarr scored 16 points in Duke's 84-50 win over Army
  • Freshman Boumtje Boumtje had 15 points and 7 rebounds for Duke
  • Army turned the ball over 24 times in the loss

Samsung Biologics Wins 434.3 Billion Won Biopharma Order

Samsung Biologics is strengthening its mid- to long-term growth drivers by continuing to win large-scale orders in the global pharmaceutical market.Samsung Biologics disclosed on Nov.

  • Samsung Biologics secures $324.8M biopharma contract with global pharma company
  • Contract valid until December 31, 2031, ensuring stable order backlog
  • Company's cumulative order value reaches $22.3B since establishment

More from Tuesday 3 November →